| |
Survivors
(
n
= 13)
|
Non-survivors
(
n
= 9)
|
P
value
|
|---|
|
Steroid therapy
|
7 (54%)
|
2 (22%)
|
0.15
|
|
IABP use
|
13 (100%)
|
8 (89%)
|
0.41
|
|
CHDF use
|
2 (15%)
|
3 (33%)
|
0.32
|
|
Total operating time of ECMO, h
|
181 ± 22
|
177 ± 31
|
0.15
|
|
Complications associated with ECMO
|
|
Total
|
3 (23%)
|
8 (89%)
|
0.004
|
|
Leg ischemia
|
0 (0%)
|
2 (22%)
|
0.16
|
|
Stroke
|
0 (0%)
|
2 (22%)
|
0.16
|
|
Bleeding
|
2 (15%)
|
6 (67%)
|
0.02
|
|
Multiple organ failure
|
2 (15%)
|
6 (67%)
|
0.02
|
- Data are presented as the mean ± standard deviation or as the number of patients (%).
-
IABP intra-aortic balloon pump, CHDF continuous hemodiafiltration.
